ATAC-seq was used to study the chromatin landscape of CD8 T cells in locally advanced melanoma patients treated with neo-adjuvant/adjuvant Pembrolizumab Overall design: CD8 naive and Non naive cells were sorted from PBMC and tumor samples from advanced melanoma patients treated with neo-adjuvant/adjuvant Pembrolizumab and chromatin accessibility was assayed for comparison analysis